These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1584840)

  • 21. Nuclear magnetic resonance detection of increased cortical GABA in vigabatrin-treated rats in vivo.
    Preece NE; Jackson GD; Houseman JA; Duncan JS; Williams SR
    Epilepsia; 1994; 35(2):431-6. PubMed ID: 8156969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of increasing doses of vigabatrin on platelet gamma-aminobutyric acid-transaminase and brain gamma-aminobutyric acid in rats.
    Valdizán EM; García AP; Armijo JA
    Eur J Pharmacol; 1999 Mar; 369(2):169-73. PubMed ID: 10206175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
    Petroff OA; Rothman DL
    Mol Neurobiol; 1998 Feb; 16(1):97-121. PubMed ID: 9554704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-allenyl GABA, a new inhibitor of 4-amino butyrate amino transferase. Comparison with other inhibitors of this enzyme.
    Jung MJ; Heydt JG; Casara P
    Biochem Pharmacol; 1984 Nov; 33(22):3717-20. PubMed ID: 6508828
    [No Abstract]   [Full Text] [Related]  

  • 25. Elevation of brain GABA levels with vigabatrin (gamma-vinylGABA) differentially affects GAD65 and GAD67 expression in various regions of rat brain.
    Sheikh SN; Martin DL
    J Neurosci Res; 1998 Jun; 52(6):736-41. PubMed ID: 9669322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential neuropathology of dogs treated with vigabatrin, a GABA-transaminase inhibitor.
    Yarrington JT; Gibson JP; Dillberger JE; Hurst G; Lippert B; Sussman NM; Heydorn WE; Marler RJ
    Toxicol Pathol; 1993; 21(5):480-9. PubMed ID: 8115824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total GABA and homocarnosine in CSF as indices of brain GABA concentrations.
    Palfreyman MG; Huot S; Grove J
    Neurosci Lett; 1983 Feb; 35(2):161-6. PubMed ID: 6856194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacology of vigabatrin.
    Schechter PJ
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):19S-22S. PubMed ID: 2667604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina.
    Neal MJ; Cunningham JR; Shah MA; Yazulla S
    Neurosci Lett; 1989 Mar; 98(1):29-32. PubMed ID: 2710396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GABAergic agents as anticonvulsants in baboons with photosensitive epilepsy.
    Meldrum B
    Neurosci Lett; 1984 Jun; 47(3):345-9. PubMed ID: 6089055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism of phencyclidine-induced hyperactivity by glycine in mice.
    Toth E; Lajtha A
    Neurochem Res; 1986 Mar; 11(3):393-400. PubMed ID: 3703107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of new gamma-aminobutyric acid amide derivatives and its phthalimide precursors on the central nervous system activity in mice.
    Mendyk A; Sałat K; Librowski T; Czarneck R; Malawska B
    Pol J Pharmacol; 2001; 53(6):689-93. PubMed ID: 11985348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy.
    Lücke A; Musshoff U; Köhling R; Osterfeld M; Mayer T; Wolf P; Schütte W; Speckmann EJ
    Br J Pharmacol; 1998 May; 124(2):370-6. PubMed ID: 9641555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
    Petroff OA; Rothman DL; Behar KL; Collins TL; Mattson RH
    Neurology; 1996 Dec; 47(6):1567-71. PubMed ID: 8960747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of vigabatrin (gamma-vinyl-gamma-aminobutyric acid) affects the levels of both inhibitory and excitatory amino acids in rat cerebrospinal fluid.
    Halonen T; Pitkänen A; Riekkinen PJ
    J Neurochem; 1990 Dec; 55(6):1870-4. PubMed ID: 2230800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
    Schmid L; Bottlaender M; Brouillet E; Fuseau C; Mazière M
    J Pharmacol Exp Ther; 1996 Mar; 276(3):977-83. PubMed ID: 8786578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of gamma aminobutyric acid on the carbon dioxide rebreathing response of normal subjects: a study using vigabatrin.
    Fennerty AG; Rimmer EM; Boulton J; Richens A
    Thorax; 1990 Jan; 45(1):42-4. PubMed ID: 2108511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis.
    Jolkkonen J; Mazurkiewicz M; Lahtinen H; Riekkinen P
    Eur J Pharmacol; 1992 Dec; 229(2-3):269-72. PubMed ID: 1490526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative studies on the anticonvulsant activity of lipophilic derivatives of gamma-aminobutyric acid and 2-pyrrolidinone in mice.
    Nakamura J; Miwa T; Mori Y; Sasaki H; Shibasaki J
    J Pharmacobiodyn; 1991 Jan; 14(1):1-8. PubMed ID: 1861236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of propyl-2-pentene-2-oic acid on GABA levels in different regions of mouse brain].
    Weissman D; Simler S; Ciesielski L; Mandel P
    C R Seances Soc Biol Fil; 1978; 172(4):707-12. PubMed ID: 154951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.